XORTX Therapeutics Inc.
XRTXCIK 0001729214
Revenue (TTM)
—
FY Dec 2021
Net Income (TTM)
−1.65M
−28.6% YoY
FY Dec 2021
EPS Diluted (TTM)
—
FY Dec 2021
Gross Margin
—
FY Dec 2021
Operating Margin
—
FY Dec 2021
Net Margin
—
FY Dec 2021
Free Cash Flow (TTM)
—
FY Dec 2021
Cash
18.85M
FY Dec 2021
Total Debt
—
FY Dec 2021
Shares Outstanding
12.99M sh
FY Dec 2021
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.